- Home
- SRRK vs OGS Comparison
SRRK vs OGS Comparison
Compare SRRK & OGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRRK
- OGS
- Stock Information
- Founded
- SRRK 2012
- OGS 1906
- Country
- SRRK United States
- OGS United States
- Employees
- SRRK N/A
- OGS N/A
- Industry
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- OGS Oil/Gas Transmission
- Sector
- SRRK Health Care
- OGS Utilities
- Exchange
- SRRK Nasdaq
- OGS Nasdaq
- Market Cap
- SRRK 4.2B
- OGS 3.8B
- IPO Year
- SRRK 2018
- OGS N/A
- Fundamental
- Price
- SRRK $37.70
- OGS $73.13
- Analyst Decision
- SRRK Strong Buy
- OGS Hold
- Analyst Count
- SRRK 7
- OGS 7
- Target Price
- SRRK $40.43
- OGS $71.64
- AVG Volume (30 Days)
- SRRK 793.4K
- OGS 449.4K
- Earning Date
- SRRK 02-27-2025
- OGS 02-19-2025
- Dividend Yield
- SRRK N/A
- OGS 3.67%
- EPS Growth
- SRRK N/A
- OGS N/A
- EPS
- SRRK N/A
- OGS 3.91
- Revenue
- SRRK N/A
- OGS $2,083,558,000.00
- Revenue This Year
- SRRK N/A
- OGS $1.69
- Revenue Next Year
- SRRK N/A
- OGS $6.51
- P/E Ratio
- SRRK N/A
- OGS $18.70
- Revenue Growth
- SRRK N/A
- OGS N/A
- 52 Week Low
- SRRK $6.76
- OGS $57.96
- 52 Week High
- SRRK $46.98
- OGS $78.89
- Technical
- Relative Strength Index (RSI)
- SRRK 41.93
- OGS 60.62
- Support Level
- SRRK $35.35
- OGS $68.58
- Resistance Level
- SRRK $38.61
- OGS $73.46
- Average True Range (ATR)
- SRRK 1.80
- OGS 1.55
- MACD
- SRRK -0.16
- OGS 0.25
- Stochastic Oscillator
- SRRK 34.20
- OGS 88.77
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.
About OGS ONE Gas Inc.
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. The company controls considerable market shares in Oklahoma and Kansas.